ACM
LGND icon

ADAR1 Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History

ADAR1 Capital Management’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-890
Closed -$75K – 317
2024
Q2 		$75K Sell
890
-25,910
-97% -$2.06M 0.01% 180
2024
Q1 		$1.96M Buy
+26,800
New +$1.98M 0.44% 45

Other funds holding LGND

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
SDJVC
St. Denis J. Villere & Co New Orleans, Louisiana $907M AUM 10.61% 1-Year Est. Return

ADAR1 Capital Management's LGND Position: Q3 2024 in Review

ADAR1 Capital Management sold out of Ligand Pharmaceuticals (LGND) in Q3 2024, closing a stake of 890 shares — an estimated $75K sold.

ADAR1 Capital Management first reported a position in LGND in Q1 2024 and held it in 2 quarters. The position peaked at $1.96M in Q1 2024. 243 funds tracked by Wall St. Rank hold LGND as of Q3 2024.

  • ADAR1 Capital Management reported no remaining Ligand Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • ADAR1 Capital Management sold 890 Ligand Pharmaceuticals shares in Q3 2024, an estimated $75K.
  • ADAR1 Capital Management first reported a position in Ligand Pharmaceuticals in Q1 2024 and held it in 2 quarters.
  • ADAR1 Capital Management's Ligand Pharmaceuticals position peaked at $1.96M in Q1 2024.
  • 243 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2024.

Based on ADAR1 Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.